Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lung Kee Group HoldingsHKSE:00255 67 Days Payable is 98.61 as of Dec. 2025, which is 12% below its 10-year median of 111.86. GuruFocus rates HKSE:00255 with a GF Score™ of 67/100 and a GF Value™ of HK$1.24 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 2,993 Industrial Products companies, Lung Kee Group Holdings ranks better than 60.67% on this metric.
The historical rank and industry rank for Lung Kee Group Holdings's Days Payable or its related term are showing as below:
HKSE:00255'
s Days Payable Range Over the Past 10 Years
Min: 75.83 Med: 111.86 Max: 164.12
Current: 100.68
During the past 13 years, Lung Kee Group Holdings's highest Days Payable was 164.12. The lowest was 75.83. And the median was 111.86.
HKSE:00255's Days Payable is ranked better than 60.67% of 2993
companies
in the Industrial Products industry
Industry Median: 77.82
vs HKSE:00255: 100.68
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00255 vs CRS, ATI, MLI: Days Payable Comparison
For the Metal Fabrication subindustry, Lung Kee Group Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lung Kee Group Holdings Days Payable vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Lung Kee Group Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Lung Kee Group Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Lung Kee Group Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lung Kee Group Holdings (HKSE:00255) has a Days Payable of 98.61 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Lung Kee Group Holdings and its competitors. This is 12% below median its historical median of 111.86. Over the past decade, Lung Kee Group Holdings' Days Payable has ranged from 75.83 to 164.12. According to the industry distribution chart, Lung Kee Group Holdings ranks #1177 out of 2993 companies in the Industrial Products industry, placing it in the top 39.3%.
Is Lung Kee Group Holdings' Days Payable too high?
Lung Kee Group Holdings' current Days Payable of 98.61 is 12% below median its 10-year median of 111.86. Over the past 10 years, this metric has ranged from a low of 75.83 to a high of 164.12. The Industrial Products industry median Days Payable is 77.82. Lung Kee Group Holdings' value of 98.61 is 26.7% above this industry median. Based on the distribution chart, Lung Kee Group Holdings ranks #1177 out of 2993 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Lung Kee Group Holdings has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lung Kee Group Holdings' Days Payable compare to CRS and ATI?
According to the Industrial Products industry distribution chart, Lung Kee Group Holdings ranks #1177 out of 2993 companies for Days Payable. This puts Lung Kee Group Holdings in the upper half of its industry. The industry median Days Payable is 77.82. Lung Kee Group Holdings' value of 98.61 is 26.7% above this benchmark. Historically, Lung Kee Group Holdings' own Days Payable has ranged from 75.83 to 164.12 over the past decade. While the company's 10-year median is 111.86 vs. the industry median of 77.82, Lung Kee Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for an Industrial Products company?
The median Days Payable among Industrial Products companies is 77.82, based on 2,993 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lung Kee Group Holdings's current Days Payable of 98.61 is 26.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Lung Kee Group Holdings and its competitors. For the Industrial Products industry, the median Days Payable is 77.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lung Kee Group Holdings's current Days Payable is 98.61, which is 12% below median its own 10-year median of 111.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lung Kee Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lung Kee Group Holdings (HKSE:00255) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$1.24, compared to a current price of HK$1.50 — trading 20.6% above its estimated fair value. The current Days Payable is 98.61, which is 12% below median its 10-year median of 111.86 and 26.7% above the Industrial Products industry median of 77.82. Lung Kee Group Holdings' overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Lung Kee Group Holdings (HKSE:00255), the current Days Payable is 98.61 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lung Kee Group Holdings (HKSE:00255) Overvalued in 2026?
Based on GuruFocus' analysis, Lung Kee Group Holdings stock appears to be overvalued.
The current stock price of HK$1.50 is trading 20.6% above its estimated GF Value™ of HK$1.24.
GuruFocus considers Lung Kee Group Holdings to be Modestly Overvalued.
Key valuation signals for HKSE:00255:
Days Payable: 98.61 (12% below median its 10-year median of 111.86)
GF Value™: HK$1.24 vs. price of HK$1.50 (20.6% above fair value)
Industry Position: 26.7% above the Industrial Products median (#1177 of 2993)
No single metric tells the full story. See the HKSE:00255 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lung Kee Group Holdings Ltd is an investment holding company that provides corporate management services. Along with its subsidiaries, it is engaged in the manufacturing and marketing of mould bases and related products. Its product offerings include standard and custom-made mould base, mould components, tool and steel products such as plastic and steel mould, hot and cold work steel, precision plates, standard mould inserts, and other materials. The company generates a majority of its revenue from the People's Republic of China and the rest from other markets like Asia, Europe, and America.
67GF Score
Get the complete analysis for HKSE:00255
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00255 has been successfully added to your 
